- Home
- BCYC vs APOG Comparison
BCYC vs APOG Comparison
Compare BCYC & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- APOG
- Stock Information
- Founded
- BCYC 2009
- APOG 1949
- Country
- BCYC United Kingdom
- APOG United States
- Employees
- BCYC N/A
- APOG N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- APOG Auto Parts:O.E.M.
- Sector
- BCYC Health Care
- APOG Consumer Discretionary
- Exchange
- BCYC Nasdaq
- APOG Nasdaq
- Market Cap
- BCYC 1.7B
- APOG 1.7B
- IPO Year
- BCYC 2019
- APOG N/A
- Fundamental
- Price
- BCYC $13.34
- APOG $55.69
- Analyst Decision
- BCYC Buy
- APOG Hold
- Analyst Count
- BCYC 9
- APOG 1
- Target Price
- BCYC $34.50
- APOG $62.00
- AVG Volume (30 Days)
- BCYC 417.9K
- APOG 332.0K
- Earning Date
- BCYC 02-18-2025
- APOG 01-07-2025
- Dividend Yield
- BCYC N/A
- APOG 1.80%
- EPS Growth
- BCYC N/A
- APOG N/A
- EPS
- BCYC N/A
- APOG 4.47
- Revenue
- BCYC $36,898,000.00
- APOG $1,377,140,000.00
- Revenue This Year
- BCYC $40.69
- APOG N/A
- Revenue Next Year
- BCYC N/A
- APOG $4.80
- P/E Ratio
- BCYC N/A
- APOG $12.47
- Revenue Growth
- BCYC 48.60
- APOG N/A
- 52 Week Low
- BCYC $12.17
- APOG $49.58
- 52 Week High
- BCYC $28.67
- APOG $87.93
- Technical
- Relative Strength Index (RSI)
- BCYC 34.88
- APOG 27.73
- Support Level
- BCYC $13.20
- APOG $49.58
- Resistance Level
- BCYC $15.43
- APOG $56.21
- Average True Range (ATR)
- BCYC 0.89
- APOG 2.84
- MACD
- BCYC 0.16
- APOG -0.92
- Stochastic Oscillator
- BCYC 6.17
- APOG 25.62
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. Its segments are Architectural Framing Systems; Architectural Glass; Architectural Services and Large-Scale Optical Technologies (LSO). It generates maximum revenue from the Architectural Framing Systems segment. The Architectural Framing Systems segment designs, engineers, fabricates, and finishes the aluminum frames used in customized aluminum and glass windows, curtainwall, storefront, and entrance systems comprising the outside skin and entrances of commercial, institutional, and others. Geographically, it derives a majority of its revenue from the United States.